• Accueil
• mcv4
• Quadrivalent Meningitis (MCV4)

Quadrivalent Meningitis (MCV4)

4.8 (195) · € 86.99 · En Stock

Teens Need BOTH Vaccines – National Meningitis Association

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine

PPT - Meningitis PowerPoint Presentation, free download - ID:1917228

Public health and economic impact of meningococcal conjugate (MCV4) vaccination in the South African HIV-positive population

A new day in preventing meningococcal disease: sizing up available vaccines - Document - Gale Academic OneFile

Selected Clinical Trials of Meningococcal Conjugate Vaccine (MCV4) and

Meningococcal ACWY

Quadrivalent meningococcal tetanus toxoid-conjugate booster vaccination in adolescents and adults: phase III randomized study

Meningococcal Vaccine Toolkit

Protecting the World Against Meningitis: New Recommendations From the CDC's Advisory Committee on Immunization Practices

Update on Prevention of Meningococcal Disease: Focus on Tetravalent Meningococcal Conjugate Vaccine

Meningococcal Vaccine Information Statement